The latest immunotherapy news and developments
Serendipity reveals new method to fight cancer with T cells
A promising therapy that treats blood cancers by harnessing the power of the immune system…
Browsing: Immunotherapy
New metabolic signature predicts immunotherapy response and survival in bladder cancer
In an innovative study published in a leading scientific journal, an international team of researchers…
Slowing inflammation may boost immunotherapy’s effectiveness against advanced lung cancer
Adding an anti-inflammatory drug to anti-PD1 checkpoint inhibitor immunotherapy has shown great promise as a…
Nano-immunotherapy developed to improve lung cancer treatment
Researchers have developed a new nanomedicine therapy that delivers anticancer drugs to lung cancer cells…
Healing by proxy: newly discovered drug may treat cancer and inflammation through indirect action
Scientists at the School of Biosciences and Veterinary Medicine at the University of Camerino (Italy) and CureLab Oncology (Boston) have…
‘Cutting the cable’ between CD8+ T and T regulatory cells enhances checkpoint immunotherapy
Checkpoint immunotherapy utilising PD-1 blockade has become the standard of care for metastatic melanoma. While…
ASCO 2024: Dual immunotherapy treatment before surgery, rather than after, improves outcomes in melanoma patients
Neoadjuvant immunotherapy given for stage III melanoma, followed by adjuvant therapy only if there is…
ASCO 2024: Immunotherapy significantly increases the number of patients free from bowel cancer
An immunotherapy drug given before surgery instead of chemotherapy meant that over ten times more…
New immunotherapy could treat osteosarcoma
A new type of immunotherapy, developed by UCL researchers in the USA, has shown promising…
‘Goldilocks’ binding strength determines anti-cancer T-cell efficacy and fate
Immunotherapy, treatments that reinvigorate immune cells’ anti-cancer activity or reprogram T cells to target cancer,…